Pvg Asset Management Corp Fortress Biotech, Inc. Transaction History

Pvg Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.48 - $13.5 $45,840 - $1.29 Million	-95,500 Closed	0 $0
Q3 2022 Oct 13, 2022	SELL	$0.79 - $22.0 $2,879 - $80,190	-3,645 Reduced 3.68%	95,500 $0
Q4 2021 Feb 02, 2022	BUY	$2.42 - $3.65 $239,930 - $361,879	99,145 New	99,145 $247,000
Q4 2019 Feb 26, 2020	SELL	$1.25 - $2.57 $98,937 - $203,415	-79,150 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$1.26 - $1.96 $99,729 - $155,134	79,150 New	79,150 $111,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Pvg Asset Management Corp with notifications on news.